KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Short term Debt: 2010-2025

Historic Short term Debt for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Sep 2025 value amounting to $1.0 billion.

  • Jazz Pharmaceuticals' Short term Debt rose 3219.93% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 3219.93%. This contributed to the annual value of $31.0 million for FY2024, which is 94.88% down from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Short term Debt is $1.0 billion, which was up 0.07% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Short term Debt registered a high of $1.0 billion during Q3 2025, and its lowest value of $31.0 million during Q3 2021.
  • Its 3-year average for Short term Debt is $421.2 million, with a median of $604.5 million in 2023.
  • Over the last 5 years, Jazz Pharmaceuticals' Short term Debt had its largest YoY gain of 3,219.93% in 2025, and its largest YoY loss of 94.88% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Short term Debt (Quarterly) stood at $31.0 million in 2021, then remained steady at $31.0 million in 2022, then skyrocketed by 1,851.46% to $605.0 million in 2023, then plummeted by 94.88% to $31.0 million in 2024, then spiked by 3,219.93% to $1.0 billion in 2025.
  • Its Short term Debt was $1.0 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $31.0 million in Q1 2025.